Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
2012 to 2015 saw rise in US insulin prices
Jun 16, 2023
However, the introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices.
AHA: Fresh produce prescription improves glycemic control
Nov 14, 2023
The findings were seen among low-income individuals with diabetes and poor glycemic control.
Diabetes increases risk for functional limitations in older adults
May 03, 2024
The findings were seen even after controlling for sociodemographic and other health factors.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
House passes bill to limit insulin costs to $35 a month
Apr 01, 2022
The bill now has to pass the Senate with at least 10 Republican votes.
Eli Lilly to slash insulin prices, cap monthly out-of-pocket costs at $35
Mar 01, 2023
The company will cut its list price for Humalog 100 units/mL starting in the fourth quarter of 2023.
Glycemic control has not been affected by pandemic
Jul 07, 2021
Despite a drop in diabetes-related outpatient visits and testing, no negative association was found with glycemic control.
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
59.5 percent of adult ED visits are for patients with chronic conditions
Sep 02, 2022
Among adults with three or more chronic conditions, Medicare was the most frequently observed expected source of payment.